Cresco Labs Inc.
CL
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 174.42M | 178.46M | 181.18M | 181.71M | 185.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 174.42M | 178.46M | 181.18M | 181.71M | 185.01M |
| Cost of Revenue | 91.88M | 86.35M | 89.58M | 92.08M | 92.09M |
| Gross Profit | 82.54M | 92.11M | 91.60M | 89.62M | 92.92M |
| SG&A Expenses | 55.33M | 57.75M | 53.51M | 54.56M | 53.49M |
| Depreciation & Amortization | 5.46M | 5.70M | 5.19M | 5.42M | 9.98M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 152.67M | 149.79M | 148.28M | 152.06M | 155.56M |
| Operating Income | 21.75M | 28.66M | 32.90M | 29.65M | 29.45M |
| Income Before Tax | 3.06M | 11.32M | -40.94M | 15.95M | 12.82M |
| Income Tax Expenses | 2.62M | 19.02M | 10.24M | 18.00M | 7.95M |
| Earnings from Continuing Operations | 439.00K | -7.69M | -51.18M | -2.06M | 4.87M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.81M | -2.85M | -3.15M | -3.14M | -2.23M |
| Net Income | -4.37M | -10.54M | -54.33M | -5.19M | 2.64M |
| EBIT | 21.75M | 28.66M | 32.90M | 29.65M | 29.45M |
| EBITDA | 35.65M | 43.59M | 47.83M | 44.98M | 49.71M |
| EPS Basic | -0.01 | -0.03 | -0.16 | -0.02 | 0.01 |
| Normalized Basic EPS | -0.01 | 0.02 | -0.08 | 0.02 | 0.01 |
| EPS Diluted | -0.01 | -0.03 | -0.16 | -0.02 | 0.01 |
| Normalized Diluted EPS | -0.01 | 0.02 | -0.08 | 0.02 | 0.01 |
| Average Basic Shares Outstanding | 347.94M | 347.36M | 344.93M | 341.63M | 339.12M |
| Average Diluted Shares Outstanding | 347.94M | 347.36M | 344.93M | 341.63M | 339.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -1.90% | -- | -- | -- |